Attention-Deficit Hyperactivity Disorder

Although substance use disorders are related to higher mortality risk among patients with attention deficit hyperactivity disorder, less information exists on the impact of ADHD medication on substance...

The FDA has approved a new option for the treatment of adolescents and adults with ADHD.

The US Food and Drug Administration has approved a new generic option for the treatment of attention-deficit/hyperactivity disorder.

Adherence to a Mediterranean Diet (MD) could be related to lower risk of attention-deficit/hyperactivity disorder (ADHD), according to a recent study.

The US Food and Drug Administration has approved the stimulant lisdexamfetamine to treat binge-eating disorder, the first product to be approved for the condition.

A new study evaluated the relationship between epilepsy and symptoms of ADHD, as well as how those symptoms affect patients' quality of life.